携带补体因子H基因罕见变异的年龄相关性黄斑变性患者的表型特征
这项横断面研究分析了51例携带CFH基因罕见变异的AMD患者(100眼)与102例年龄匹配的非携带者(204眼),发现携带者更常见大面积玻璃膜疣、结晶样玻璃膜疣及视盘鼻侧玻璃膜疣。作者认为仅凭彩色眼底表型难以区分携带者,建议结合早发、荧光素血管造影见角质样玻璃膜疣及AMD家族史等情况考虑基因检测。
要点
- 携带CFH罕见变异的AMD患者更常见大面积玻璃膜疣(OR范围6.98至18.50)。
- 结晶样玻璃膜疣与携带状态相关(OR 3.24,95%CI 1.24-8.50)。
- 视盘鼻侧玻璃膜疣与携带状态相关(OR范围4.03至7.42)。
核心结论
- 识别CFH罕见变异携带者对即将到来的补体抑制治疗可能重要。
- 具有大面积玻璃膜疣、结晶样玻璃膜疣和视盘鼻侧玻璃膜疣的患者更可能携带CFH基因罕见变异。
- 仅凭彩色眼底图像的表型特征不太可能区分携带者与非携带者。
- 作者建议对具有上述表型特征并结合其他患者特征(如早发、荧光素血管造影见角质样玻璃膜疣和AMD家族史)的患者考虑基因检测。
研究设计与样本
- 横断面研究,检索Radboudumc眼科(三级眼科转诊中心)遗传数据库和欧洲遗传数据库中的AMD患者。
- 患者招募时间为2006年3月30日至2013年2月18日,数据分析时间为2015年11月30日至2017年5月8日。
- 纳入51例携带CFH变异的AMD患者(100眼,平均[SD]年龄66.7[12.1]岁,64.7%女性)和102例年龄匹配的非携带者(204眼,平均[SD]年龄67.1[11.8]岁,54.9%女性)。
- 由2名对携带状态设盲的独立阅片中心评分者对患者双眼眼底照片进行表型特征分级。
- 使用单变量广义估计方程逻辑回归模型分析携带者与非携带者间表型特征差异,并考虑眼间相关性。
主要发现
- 携带罕见致病性CFH变异与更大玻璃膜疣面积相关(OR范围6.98[95%CI 2.04-23.89]至18.50[95%CI 2.19-155.99];P=0.002)。
- 携带罕见致病性CFH变异与结晶样玻璃膜疣存在相关(OR 3.24;95%CI 1.24-8.50;P=0.02)。
- 携带罕见致病性CFH变异与视盘鼻侧玻璃膜疣相关(OR范围4.03[95%CI 1.70-9.56]至7.42[95%CI 0.65-84.84];P=0.003)。
临床怎么用
- 作者认为,识别CFH罕见变异携带者对即将到来的补体抑制治疗可能重要。
- 作者建议,对具有大面积玻璃膜疣、结晶样玻璃膜疣和视盘鼻侧玻璃膜疣的患者,结合其他患者特征(如早发、荧光素血管造影见角质样玻璃膜疣和AMD家族史)考虑基因检测。
- 作者指出,仅凭彩色眼底图像的表型特征不太可能区分携带者与非携带者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Rare variants in the complement factor H (CFH) gene and their association with age-related macular degeneration (AMD) have been described. However, there is limited literature on the phenotypes accompanying these rare variants. Phenotypical characteristics could help ophthalmologists select patients for additional genetic testing. OBJECTIVE: To describe the phenotypical characteristics of patients with AMD carrying a rare variant in the CFH gene. DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study, we searched the genetic database of the department of ophthalmology at the Radboudumc (tertiary ophthalmologic referral center) and the European Genetic Database for patients with AMD with a rare genetic variant in the CFH gene. Patient recruitment took place from March 30, 2006, to February 18, 2013, and data were analyzed from November 30, 2015, to May 8, 2017. Phenotypical features on fundus photographs of both eyes of patients were graded by 2 independent reading center graders masked for carrier status. MAIN OUTCOMES AND MEASURES: Differences in phenotypical characteristics between rare variant carriers and noncarriers were analyzed using univariable generalized estimated equations logistic regression models accounting for intereye correlation. RESULTS: Analyses included 100 eyes of 51 patients with AMD carrying a CFH variant (mean [SD] age, 66.7 [12.1] years; 64.7% female) and 204 eyes of 102 age-matched noncarriers (mean [SD] age, 67.1 [11.8] years; 54.9% female). Carrying a rare pathogenic CFH variant was associated with larger drusen area (odds ratio range, 6.98 [95% CI, 2.04-23.89] to 18.50 [95% CI, 2.19-155.99]; P = .002), presence of drusen with crystalline appearance (odds ratio, 3.24; 95% CI, 1.24-8.50; P = .02), and drusen nasal to the optic disc (odds ratio range, 4.03 [95% CI, 1.70-9.56] to 7.42 [95% CI, 0.65-84.84]; P = .003). CONCLUSIONS AND RELEVANCE: Identification of rare CFH variant carriers may be important for upcoming complement-inhibiting therapies. Patients with an extensive drusen area, drusen with crystalline appearance, and drusen nasal to the optic disc are more likely to have a rare variant in the CFH gene. However, it is not likely that carriers can be discriminated from noncarriers based solely on phenotypical characteristics from color fundus images. Therefore, ophthalmologists should consider genetic testing in patients with these phenotypic characteristics in combination with other patient characteristics, such as early onset, cuticular drusen on fluorescein angiography, and family history of AMD.
引用
- Kersten E, Geerlings MJ, den Hollander AI, et al. Phenotype Characteristics of Patients With Age-Related Macular Degeneration Carrying a Rare Variant in the Complement Factor H Gene. JAMA Ophthalmol. 2017. PMID: 28859202. doi:10.1001/jamaophthalmol.2017.3195
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。